Sign In   Register

Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com

Lexaria Bioscience says close to winning new patent for its flagship DehydraTECH technology

The group has received a Notice of Allowance from the US Patent and Trademark Office for a new patent to protect the use of its technology in mix-and-...

Lexaria Bio Science files patent for technology to treat infection disease including Corona

What are you searching for? viewLexaria Bioscience Corp. Lexaria Bioscience (CSE: LXX-OTC: LXRP) CEO Chris Bunka joined Steve Darling from Proactive V...

Lexaria Bioscience joins fight against coronavirus as it files new US patent for drug delivery technology

The firm's patented drug delivery technology changes the way active pharmaceutical ingredients enter a patient's bloodstream Acute respiratory distres...

Lexaria Bioscience widens scope of pharmaceutical subsidiary in bid to develop treatment for coronavirus

Lexaria Pharmaceutical will look at how DehydraTECH could improve delivery and effectiveness of antiviral drugs to treat coronavirus Researchers are l...

Lexaria Bio Science working with frontline companies to battle COVID-19

What are you searching for? viewLexaria Bioscience Corp. Lexaria Bioscience (CSE:LXX-OTCQX: LXRP) CEO Chris Bunka joined Steve Darling from Proactive ...

Lexaria Bioscience initiates coronavirus drug delivery program

The program will study the benefits of its DehydraTECH technology for boosting the delivery and effectiveness of fat-soluble antiretroviral drugs Lexa...

Lexaria Bioscience produces first DehydraTECH-enabled CBD emulsion for licensed client

The super-concentrated DehydraTECH-enabled liquid nanoemulsion was shipped to the client's production facility for incorporation into its cold-brewed ...

Lexaria Bioscience explains benefit of its CBD infused powders against backdrop of consumer concerns on potency

DehydraTECH turns cannabis and hemp oils into stabilized powders, which allows for faster absorption Lexaria sells its pre-processed CBD/hemp DehydraT...

Buds & Duds: Cannabis stocks hold steady; Lexaria rises on amended agreement with Cannadips

What are you searching for? The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, inched 0.2% higher at 122.9...

Buds & Duds: Cannabis stocks hold steady; Lexaria rises on amended agreement with Cannadips

A series of incremental gains over the past few days point to optimism creeping back into the sector Also on the move was Curaleaf, Bhang and Betterli...

Lexaria Bioscience beefs up licensing deal providing DehydraTECH to Cannadips Cannabis

DehydraTECH masks unwanted taste, improves onset speed and increases bioavailability of active ingredients Cannadips Cannabis Tins contain 15 pouches ...

Lexaria Bioscience and Cannadips CEO’s discuss key point of massive deal together

What are you searching for? viewLexaria Bioscience Corp. Lexaria BioScience (OTC: LXRP-CSE: LXX) CEO Chris Bunka and Case Mandel, CEO of Cannadips joi...

Lexaria BioScience signs massive licensing deal with Cannadips CBD

What are you searching for? viewLexaria Bioscience Corp. Lexaria BioScience (OTC: LXRP-CSE: LXX) CEO Chris Bunka joined Steve Darling from Proactive V...

Buds & Duds: Lexaria Bioscience shines while Aphria tumbles on slashed revenue outlook

Lexaria sealed an agreement to provide its patented DehydraTECH technology to Cannadips CBD Cannabis indices held steady overall Cannabis stocks were ...

Lexaria Bioscience strikes licensing pact to provide DehydraTECH to Cannadips CBD

DehydraTECH masks unwanted taste, improves onset speed and increases bioavailability of active ingredients Since Cannadips uses terpene-rich multi spe...

Lexaria BioScience CEO releases letter to shareholders as company looks for big 2020

What are you searching for? viewLexaria Bioscience Corp. Lexaria BioScience (CSE:LXX-OTCQX: LXRP) CEO Chris Bunka joined Steve Darling from Proactive ...

Lexaria Bioscience planning to list on a major US exchange in 2020, says CEO

The statement from CEO Chris Bunka came as part of a shareholder letter published on Thursday that outlined strategic plans for the year Lexaria plans...

Lexaria Bioscience further enhances drug delivery platform as human tests show it delivers THC within 10 minutes

It was tested in pilot human tests using edibles and this enhanced version is around twice as fast as traditional DehydraTECH Further testing and eval...

Lexaria Bioscience closes US$700,000 financing to fund research into DehydraTECH

What are you searching for? viewLexaria Bioscience Corp. The funds raised will go towards research and development of the company’s innovative Dehydra...

Buds & Duds: Cannabis stocks show signs of life ahead of earnings season

The coming month will provide "a lot more color" of where the overall cannabis industry stands, according to Roth analyst Movers in positive territory...


MjInvest.com